Porton Advanced's UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance

RegulatoryUC-MSCs Cell BankPositive

AI Analysis

Summary

Porton Advanced announced FDA acceptance of its Drug Master File for a Umbilical Cord-Derived Mesenchymal Stem Cell Bank intended for exosome manufacturing, a regulatory milestone supporting the development of cell-derived exosome therapeutics.

Outcome Details

FDA Drug Master File (DMF) acceptance for UC-MSCs Cell Bank for exosome manufacturing

Importance:6/10

Sentiment:

0.70

FDA approvalcell therapyexosome manufacturingDrug Master Fileregenerative medicine

Related Companies

$CHHE

Read the original article

Published by PR Newswire Pharma on July 8, 2026 1:38 PM

Read Original